Document is current
Any future updates will be listed below
-
Authors
Ignatiadis, Michail http://orcid.org/0000-0002-4493-3748
Sledge, George W. http://orcid.org/0000-0003-0297-0775
Jeffrey, Stefanie S. http://orcid.org/0000-0003-4478-2764
- License Information
-
More Information
Article History
Accepted: 23 November 2020
First Online: 20 January 2021
Competing interests
: M.I. has received consultancy fees from Celgene, Novartis, Pfizer, Seattle Genetics and Tesaro, and travel grants from Amgen and Pfizer. The institution of M.I. has received research grants from Menarini Silicon Biosystems and Natera. G.W.S. is a member of the Board of Directors of Tessa Therapeutics and of the Scientific Advisory Boards of Syndax and Verseau Therapeutics. S.S.J. serves as a scientific advisor for Quantumcyte and Ravel Biotechnology.
